AptaBio Therapeutics Stock Forecast - Price Action Indicator
| 293780 Stock | 6,310 100.00 1.56% |
AptaBio Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast AptaBio Therapeutics stock prices and determine the direction of AptaBio Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of AptaBio Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
AptaBio |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (125.00) | (150.00) |
| Check AptaBio Therapeutics Volatility | Backtest AptaBio Therapeutics | Information Ratio |
AptaBio Therapeutics Trading Date Momentum
| On November 15 2024 AptaBio Therapeutics was traded for 6,310 at the closing time. The highest price during the trading period was 6,680 and the lowest recorded bid was listed for 6,140 . The volume for the day was 78.5 K. This history from November 15, 2024 did not affect price variability. The overall trading delta to the current price is 1.27% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare AptaBio Therapeutics to competition |
Other Forecasting Options for AptaBio Therapeutics
For every potential investor in AptaBio, whether a beginner or expert, AptaBio Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. AptaBio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in AptaBio. Basic forecasting techniques help filter out the noise by identifying AptaBio Therapeutics' price trends.AptaBio Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AptaBio Therapeutics stock to make a market-neutral strategy. Peer analysis of AptaBio Therapeutics could also be used in its relative valuation, which is a method of valuing AptaBio Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
AptaBio Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of AptaBio Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of AptaBio Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
AptaBio Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how AptaBio Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AptaBio Therapeutics shares will generate the highest return on investment. By undertsting and applying AptaBio Therapeutics stock market strength indicators, traders can identify AptaBio Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 6346.29 | |||
| Daily Balance Of Power | (0.19) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 6410.0 | |||
| Day Typical Price | 6376.67 | |||
| Market Facilitation Index | 0.0069 | |||
| Price Action Indicator | (150.00) | |||
| Period Momentum Indicator | (100.00) |
AptaBio Therapeutics Risk Indicators
The analysis of AptaBio Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in AptaBio Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aptabio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.13 | |||
| Standard Deviation | 4.18 | |||
| Variance | 17.47 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with AptaBio Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AptaBio Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with AptaBio Stock
Moving against AptaBio Stock
The ability to find closely correlated positions to AptaBio Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AptaBio Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AptaBio Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AptaBio Therapeutics to buy it.
The correlation of AptaBio Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AptaBio Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AptaBio Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AptaBio Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in AptaBio Stock
AptaBio Therapeutics financial ratios help investors to determine whether AptaBio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AptaBio with respect to the benefits of owning AptaBio Therapeutics security.